IL2 and metabolic syndrome: Recent study on PAHs exposure in small population suggested elevation of inflammation (IL2, IL6, IL8) and oxidative stress marker (MDA) in prediabetic patients, indicating a metabolic syndrome enhanced oxidative damage [32].